News Conference News AHA 2016 Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention Yael L. Maxwell November 29, 2016
News Industry News Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat May 26, 2015
News Industry News CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference May 26, 2015
News Daily News Model Suggests Renal Denervation Cost-effective for Resistant Hypertension September 13, 2012
News Daily News Halving DES Use in Low-Risk Patients Could Save $200 Million Annually Yael L. Maxwell July 11, 2012